The appeal of these diverse careers often lies in the different types of impact they enable. A PhD can teach more than ...

BioSyent Inc. ("BioSyent", "the Company", TSX Venture: RX) is pleased to announce that the TSX Venture Exchange ("TSX-V") has accepted the Company's Notice of Intention to Make a Normal Course Issuer ...

Johnson & Johnson will host a conference call for investors at 8:30 a.m. (Eastern Time) on Wednesday, January 21st to review fourth-quarter results. Joaquin Duato, Chairman and Chief Executive Officer ...

Patients with chronic spontaneous urticaria experienced relief in itch and hives by day 3 with povorcitinib, according to ...

Here’s a closer look at the top pharmaceutical companies that have earned favorable rankings from Wolfe Research analysts. Johnson & Johnson takes the top spot with growth primarily driven by new ...

South Korea-based ADEL said late on Monday that it has entered a $1.04 billion partnership with French drugmaker Sanofi to ...

Reporting on ASH 2025, Dr Jamile Shammo highlights long-term follow-up data for established paroxysmal nocturnal ...

Federal officials say the FDA is reviewing reports of possible deaths in adults and children following COVID-19 vaccination.

Federal regulators have begun a safety review of 2 RSV medicines used to protect infants, even though no safety problems have been reported.

On December 12, 2025, the US Food and Drug Administration approved Johnson & Johnson subsidiary Janssen Biotech’s Akeega (niraparib and abiraterone acetate with prednisone for adults with deleterious ...

The next few years of projected revenues in the pharma space have more holes in them than industry CEOs’ favorite golf ...